Skip to content

Clinical trials

Completed Prostatic Hyperplasia trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Status: Completed Country / region: South Korea Clear all

52 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20042
20052
20063
20072
20081
20091
20105
20113
20123
20132
20147
20157
20162
20171
20194
20201
20211
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Samsung Medical Center9
Chong Kun Dang Pharmaceutical7
GlaxoSmithKline4
Hanmi Pharmaceutical Company Limited4
JW Pharmaceutical4
Dongkook Pharmaceutical Co., Ltd.3
Allergan2
Eli Lilly and Company2
GemVax & Kael2
Jeil Pharmaceutical Co., Ltd.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia52
Lower Urinary Tract Symptoms6
Urinary Bladder, Overactive5
Erectile Dysfunction2
Prostatic Neoplasms2
Nocturia1
Urinary Bladder Neck Obstruction1
Urinary Bladder Neoplasms1

Trials

Showing 1 to 25 of 52. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.